http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02070478-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8adf1aa119f2fa8c92dc31e5ef07b387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7df3e3ca305186c10ab3c60109f1de2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34 |
filingDate | 2002-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a78c77c1f3b61d6570989fb40382d9c7 |
publicationDate | 2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-02070478-A1 |
titleOfInvention | Indolone derivatives having vascular-damaging activity |
abstract | This invention relates to the use of compounds of Formula (I) as vascular damaging agents: wherein X is selected from: -O-, -S-, -S(O)-, -S(O2)-, -N(R5)-, -C(O)-, -C(O)N(R5)-, -N(R5)C(O)-, -S(O2)N(R5)-, or -N(R5)S(O2)-; R1 is independently selected from: amino, halo, hydroxy, -OPO3H2, C1-4alkyl, or C1-4alkoxy, wherein the amino group is optionally substituted by an amino acid residue and the hydroxy group is optionally esterified; R2 is selected from: hydrogen or C1-4alkyl; R3 is selected from: hydrogen, halo, hydroxy, hydroxyC1-4alkyl, cyano, cyanoC1-4alkyl, carboxy, carboxyC1-4alkyl, C1-4alkanoyl, C1-4alkanoylC1-4alkyl, carbamoyl, carbamoylC1-4alkyl, C1-4alkoxy, C1-4alkoxycarbonyl, C1-4alkoxycarbonylC1-4alkyl, C1-4alkoxycarbonylamino, amino, N-C1-4alkylamino, NN-diC1-4alkylamino, aminoC1-4alkyl, N-C1-4alkylaminoC1-4alkyl, NN-diC1-4alkylaminoC1-4alkyl, ureido, or C1-4alkylureyleno; R4 is independently selected from: C1-4alkyl, C1-4alkoxy or halo; R5 is selected from: hydrogen or C1-4alkyl; n is 0 or 1; p is 0, 1, 2 or 3; and q is 0,1 or 2; or a salt, pro-drug or solvate thereof. The invention also relates to novel compounds of Formula (I) and to processes for the preparation of compounds of Formula (I). |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03082271-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03082271-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7125906-B2 |
priorityDate | 2001-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 412.